Evolva and Cornelius Group Bring New Fermented Resveratrol to Market
28 Jul 2016 --- Evolva have announced teaming up with Cornelius Group, an independent European distributor of high quality ingredients, for the marketing of resveratrol in certain European markets. Evolva’s resveratrol is produced via an innovative fermentation process using yeast.
Resveratrol is an ingredient found in red grapes, blueberries, nuts and other plants. There is already a significant body of evidence showing that resveratrol can produce a positive impact on healthy-ageing variables like heart health, bone health, and blood-glucose control. Scientists have also found evidence in key biomarkers that resveratrol might slow the progression of Alzheimer’s disease and mimic the effects of a calorie-restricted diet. Evolva’s resveratrol comes from a fermentation process, producing a high-purity ingredient free of any environmental contaminants.
Joy Thomas, technical manager, Cornelius Group said: “Most resveratrol on the market today comes from the Japanese knotweed plant. Evolva’s resveratrol is different and is manufactured via the fermentation of yeast, making it a pure product that is free of pesticides and other impurities that can be found in knotweed extracts.”
The fermented resveratrol from Evolva has a purity over 98 per cent and is suitable for a broad range of products from capsules and tablets for dietary supplements to more complex applications in foods, animal nutrition and personal care products. Cornelius has a strong position in these application markets. As the exclusive distributor for Evolva’s fermented resveratrol, Cornelius will supply the ingredient to the UK, Republic of Ireland, Denmark, Norway, Sweden and Finland foods market, countries with a total population 96 million.
Ms Thomas added “Consumers are now demanding formulations derived from natural sources. The clean label trend is now seen more as a consumer expectation, as well as an industry standard. Fermentation of Evolva’s resveratrol is a natural process and supports the current market and consumer trends”.
Evolva CEO Neil Goldsmith, said: “Much of the resveratrol sold today is made from knotweed, which results in a lack of control over the standard of crop. The benefit of using the fermentation process is that it ensures the quality of the ingredient. Manufacturing resveratrol through the fermentation of yeast offers us, and our customers, peace of mind as it’s made from natural and sustainable feedstocks and has a stable, traceable and reliable supply chain.”
This distribution agreement does not change Evolva’s revenue guidance for 2016.
Earlier this year, Evolva announced that the European Patent Office granted the Company patent number 2742142, intellectual property pivotal to the commercial expansion of and broader access to the best-tasting stevia-sweeteners made possible through the introduction of yeast fermentation-derived steviol glycosides. Evolva currently has 54 patents pending around the world related to yeast fermentation-derived steviol glycosides and they now have four commercially relevant stevia sweetener patents granted.
18 Apr 2024 --- As the F&B industry grapples with food waste, scientists in Singapore have tapped into a technology to extract 80% of the available protein from...Read More
16 Apr 2024 --- Companies are developing novel ways to mitigate the current challenges in the cocoa industry. Climate-induced drought, broader biodiversity issues and...Read More
05 Apr 2024 --- In industry news this week, Beneo plans to install new equipment at its rice ingredients plant in Wijgmaal, Belgium, including a large-scale industrial...Read More
03 Apr 2024 --- German ingredient formulator GoodMills Innovation has unveiled its range of Tip-Top Ultra Clean release flours that reduce the fine dust produced in...Read More
03 Apr 2024 --- There is an increasing demand for coloring food ingredients that offer clean label options across F&B applications. This is often accompanied by...Read More